LONDON (Alliance News) - GlaxoSmithKline PLC said Thursday its asthma and chronic obstructive pulmonary disease drug Relvar Ellipta has received a "positive" EU approval with regards its use and ...
The EU has demanded that the United States stick to the terms of a trade deal they agreed last year after the U.S. Supreme Court struck down President Donald Trump's global tariffs and he responded ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results